The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

MÜLLER, N ; SCHWARZ, M. J ; MÖLLER, H.-J ; AROLT, V ; RIEDEL, M ; DEHNING, S ; DOUHE, A ; CEROVECKI, A ; GOLDSTEIN-MÜLLER, B ; SPELLMANN, I ; HETZEL, G ; MAINO, K ; KLEINDIENST, N

Molecular psychiatry, 2006-07, Vol.11 (7), p.680-684 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível